Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-006835

Chief Executive Officer sold 49,299 shares at an average $65.19 ($3,213,653)

  • Chief Executive Officer acquired 49,299 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-26 Exercise or conversion : show line 1 in the form 10b5-1 +24,282 $8.82 $214,167 871,154 D
2026-05-26 Sale : show line 2 in the form 10b5-1 −24,282 $65.08 $1,580,246 846,872 D
2026-05-27 Exercise or conversion : show line 3 in the form 10b5-1 +25,017 $8.82 $220,650 871,889 D
2026-05-27 Sale : show line 4 in the form 10b5-1 −23,752 $65.24 $1,549,561 848,137 D
2026-05-27 Sale : show line 5 in the form 10b5-1 −1,265 $66.28 $83,846 846,872 D
Open-market sales · 49,299 sh · avg $65.19 · $3,213,653

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-26 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) +24,282 116,926 D
2026-05-27 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) +25,017 91,909 D
Loading xslF345X06/marketforms-73281.xml…